Abstract |
A novel rubella candidate vaccine based on a structurally modified plant virus - spherical particles (SPs) - was developed. SPs generated by the thermal remodelling of the tobacco mosaic virus are promising platforms for the development of vaccines. SPs combine unique properties: biosafety, stability, high immunogenicity and the effective adsorption of antigens. We assembled in vitro and characterised complexes (candidate vaccine) based on SPs and the rubella virus recombinant antigen. The candidate vaccine induced a strong humoral immune response against rubella. The IgG isotypes ratio indicated the predominance of IgG1 which plays a key role in immunity to natural rubella infection. The immune response was generally directed against the rubella antigen within the complexes. We suggest that SPs can act as a platform (depot) for the rubella antigen, enhancing specific immune response. Our results demonstrate that SPs- antigen complexes can be an effective and safe candidate vaccine against rubella.
|
Authors | Ekaterina A Trifonova, Vladimir A Zenin, Nikolai A Nikitin, Maria S Yurkova, Ekaterina M Ryabchevskaya, Egor V Putlyaev, Ekaterina K Donchenko, Olga A Kondakova, Alexey N Fedorov, Joseph G Atabekov, Olga V Karpova |
Journal | Antiviral research
(Antiviral Res)
Vol. 144
Pg. 27-33
(08 2017)
ISSN: 1872-9096 [Electronic] Netherlands |
PMID | 28511994
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2017 Elsevier B.V. All rights reserved. |
Chemical References |
- Antibodies, Viral
- Drug Carriers
- Immunoglobulin G
- Rubella Vaccine
- Vaccines, Synthetic
|
Topics |
- Animals
- Antibodies, Viral
(blood)
- Drug Carriers
- Immunoglobulin G
(blood)
- Mice, Inbred BALB C
- Rubella Vaccine
(administration & dosage, genetics, immunology)
- Rubella virus
(genetics, immunology)
- Tobacco Mosaic Virus
(genetics)
- Vaccines, Synthetic
(administration & dosage, genetics, immunology)
|